| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10692 | 2021 |
| First non-ATP competitive glycogen synthase kinase 3 β (GSK-3β) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease A Martinez, M Alonso, A Castro, C Pérez, FJ Moreno Journal of medicinal chemistry 45 (6), 1292-1299, 2002 | 596 | 2002 |
| Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation A Martinez, A Castro, I Dorronsoro, M Alonso Medicinal research reviews 22 (4), 373-384, 2002 | 496 | 2002 |
| COVID-19: drug targets and potential treatments C Gil, T Ginex, I Maestro, V Nozal, L Barrado-Gil, MÁ Cuesta-Geijo, ... Journal of medicinal chemistry 63 (21), 12359-12386, 2020 | 422 | 2020 |
| GSK-3 inhibitors: preclinical and clinical focus on CNS H Eldar-Finkelman, A Martinez Frontiers in molecular neuroscience 4, 32, 2011 | 387 | 2011 |
| Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary … M Sánchez-de-la-Torre, A Sánchez-de-la-Torre, S Bertran, J Abad, ... The Lancet Respiratory Medicine 8 (4), 359-367, 2020 | 327 | 2020 |
| Maternal and perinatal factors influencing the duration of exclusive breastfeeding during the first 6 months of life JMC Cernadas, G Noceda, L Barrera, AM Martinez, A Garsd Journal of human lactation 19 (2), 136-144, 2003 | 325 | 2003 |
| Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease P Muñoz-Ruiz, L Rubio, E García-Palomero, I Dorronsoro, ... Journal of medicinal chemistry 48 (23), 7223-7233, 2005 | 251 | 2005 |
| Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors A Castro, A Martinez Current pharmaceutical design 12 (33), 4377-4387, 2006 | 247 | 2006 |
| Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor γ activation R Luna-Medina, M Cortes-Canteli, M Alonso, A Santos, A Martínez, ... Journal of Biological Chemistry 280 (22), 21453-21462, 2005 | 239 | 2005 |
| Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease A Castro, A Martinez Mini reviews in medicinal chemistry 1 (3), 267-272, 2001 | 207 | 2001 |
| Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE D Alonso, I Dorronsoro, L Rubio, P Munoz, E García-Palomero, ... Bioorganic & medicinal chemistry 13 (24), 6588-6597, 2005 | 206 | 2005 |
| Tacrine–melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties MI Fernández‐Bachiller, C Pérez, NE Campillo, JA Páez, ... ChemMedChem: Chemistry Enabling Drug Discovery 4 (5), 828-841, 2009 | 201 | 2009 |
| TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice Y Cheng, S Desse, A Martinez, RJ Worthen, RS Jope, E Beurel Brain, behavior, and immunity 69, 556-567, 2018 | 195 | 2018 |
| Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases DI Perez, C Gil, A Martinez Medicinal research reviews 31 (6), 924-954, 2011 | 182 | 2011 |
| Manzamine B and E and Ircinal A Related Alkaloids from an Indonesian Acanthostrongylophora Sponge and Their Activity against Infectious, Tropical Parasitic … KV Rao, MS Donia, J Peng, E Garcia-Palomero, D Alonso, A Martinez, ... Journal of natural products 69 (7), 1034-1040, 2006 | 181 | 2006 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 172 | 2021 |
| Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure–activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer’s disease M Hamann, D Alonso, E Martín-Aparicio, A Fuertes, MJ Pérez-Puerto, ... Journal of Natural Products 70 (9), 1397-1405, 2007 | 167 | 2007 |
| Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo JA Morales-Garcia, R Luna-Medina, S Alonso-Gil, M Sanz-SanCristobal, ... ACS chemical neuroscience 3 (11), 963-971, 2012 | 165 | 2012 |
| SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors A Martinez, M Alonso, A Castro, I Dorronsoro, JL Gelpí, FJ Luque, C Pérez, ... Journal of Medicinal Chemistry 48 (23), 7103-7112, 2005 | 165 | 2005 |
